Literature DB >> 25115630

Diaminoglyoxime as a versatile reagent in the synthesis of bis(1,2,4-oxadiazoles), 1,2,4-oxadiazolyl-quinazolines and 1,2,4-oxadiazolyl-benzothiazinones.

Rahim Hosseinzadeh Khanmiri1, Abolghasem Moghimi, Ahmad Shaabani, Hassan Valizadeh, Seik Weng Ng.   

Abstract

The synthesis of bis(1,2,4-oxadiazoles), 1,2,4-oxadiazolyl-quinazolines, and 1,2,4-oxadiazolyl-benzothiazinones has been investigated by the reaction of diaminoglyoxime with various ketones and methyl 2-aminobenzoate, 2-amino-5-chlorophenyl)(phenyl)methanone, and 2-mercapto benzoic acid in acetic acid either a catalyst or solvent at 100 °C.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25115630     DOI: 10.1007/s11030-014-9536-4

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  27 in total

1.  Synthesis and pharmacological study of ethyl 1-methyl-5-(substituted 3,4-dihydro-4-oxoquinazolin-3-yl)-1H-pyrazole-4-acetates.

Authors:  B Maggio; G Daidone; D Raffa; S Plescia; L Mantione; V M Catena Cutuli; N G Mangano; A Caruso
Journal:  Eur J Med Chem       Date:  2001-09       Impact factor: 6.514

2.  Discovery of a long-acting, peripherally selective inhibitor of catechol-O-methyltransferase.

Authors:  László E Kiss; Humberto S Ferreira; Leonel Torrão; Maria João Bonifácio; P Nuno Palma; Patrício Soares-da-Silva; David A Learmonth
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

3.  A novel isocyanide-based three-component reaction: synthesis of highly substituted 1,6-dihydropyrazine-2,3-dicarbonitrile derivatives.

Authors:  Ahmad Shaabani; Ali Maleki; Jafar Moghimi-Rad
Journal:  J Org Chem       Date:  2007-07-04       Impact factor: 4.354

4.  The new era of 1,2,4-oxadiazoles.

Authors:  Andrea Pace; Paola Pierro
Journal:  Org Biomol Chem       Date:  2009-09-16       Impact factor: 3.876

5.  Antihyperglycemic activity of new 1,2,4-oxadiazolidine-3,5-diones.

Authors:  M S Malamas; J Sredy; M McCaleb; I Gunawan; B Mihan; D Sullivan
Journal:  Eur J Med Chem       Date:  2001-01       Impact factor: 6.514

6.  Convenient synthesis and biological profile of 5-amino-substituted 1,2,4-oxadiazole derivatives.

Authors:  Maria Ispikoudi; Michalis Amvrazis; Christos Kontogiorgis; Alexandros E Koumbis; Konstantinos E Litinas; Dimitra Hadjipavlou-Litina; Konstantina C Fylaktakidou
Journal:  Eur J Med Chem       Date:  2010-09-17       Impact factor: 6.514

7.  Synthesis, characterization, cellular uptake and interaction with native DNA of a bis(pyridyl)-1,2,4-oxadiazole copper(II) complex.

Authors:  Alessio Terenzi; Giampaolo Barone; Antonio Palumbo Piccionello; Gianluca Giorgi; Annalisa Guarcello; Patrizia Portanova; Giuseppe Calvaruso; Silvestre Buscemi; Nicolò Vivona; Andrea Pace
Journal:  Dalton Trans       Date:  2010-08-27       Impact factor: 4.390

8.  Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.

Authors:  Dalip Kumar; Gautam Patel; Emmanuel O Johnson; Kavita Shah
Journal:  Bioorg Med Chem Lett       Date:  2009-04-05       Impact factor: 2.823

9.  Discovery of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers. 2. Identification of more aqueous soluble analogs as potential anticancer agents.

Authors:  William Kemnitzer; Jared Kuemmerle; Han-Zhong Zhang; Shailaja Kasibhatla; Ben Tseng; John Drewe; Sui Xiong Cai
Journal:  Bioorg Med Chem Lett       Date:  2009-05-18       Impact factor: 2.823

10.  Synthesis of novel 4,6-disubstituted quinazoline derivatives, their anti-inflammatory and anti-cancer activity (cytotoxic) against U937 leukemia cell lines.

Authors:  P Mani Chandrika; T Yakaiah; A Raghu Ram Rao; B Narsaiah; N Chakra Reddy; V Sridhar; J Venkateshwara Rao
Journal:  Eur J Med Chem       Date:  2007-07-06       Impact factor: 6.514

View more
  1 in total

1.  Synthesis of 2-(1,2,4-oxadiazol-3-yl)quinazolin-4(3H)-ones from diaminoglyoxime-based nitrones.

Authors:  Rahim Hosseinzadeh-Khanmiri; Abolghasem Moghimi; Ahmad Shaabani; Hassan Valizadeh; Seik Weng Ng
Journal:  Mol Divers       Date:  2015-04-22       Impact factor: 2.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.